Omega 3 Prescription Drugs Market Size
Pharmaceuticals

Omega 3 Prescription Drugs Global Market Outlook 2023-2032: Size And Growth Rate Analysis

The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

As per The Business Research Company’s Omega 3 Prescription Drugs Global Market Report 2023, The global omega 3 prescription drugs market is expected to grow from $1.37 billion in 2022 to $1.49 billion in 2023 at a compound annual growth rate (CAGR) of 8.74%. The omega 3 prescription drugs market size is expected to reach $2.09 billion in 2027 at a CAGR of 8.84%.

What was the major driver in the omega 3 prescription drugs market?
Rising cardiovascular disease (CVD) incidences are predicted to fuel the rise of the omega-3 prescription medication industry. Increased blood triglyceride levels (a fatty-like substance) have been related to an increased risk of cardiovascular disease, and omega-3 supplements help to regulate and lower triglyceride levels. According to the World Health Organisation (WHO) report for 2021, an estimated 17.9 million individuals died from CVDs in 2021, accounting for 32% of global fatalities. Heart attacks and strokes were the causes of 85% of these fatalities. As a result, increased cardiovascular disease (CVD) cases support the expansion of the omega-3 prescription medicine industry.

View More On The Omega 3 Prescription Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/omega-3-prescription-drugs-global-market-report

What was the key trend in the omega 3 prescription drugs market?
In the omega-3 prescription medicine industry, new product innovations have emerged as a prominent trend. To increase their market position, major companies involved in the production of omega-3 pharmaceuticals are focusing on generating new product developments. For example, in October 2022, the European Commission approved DSM’s plant-based omega-3 products for use as fish and animal alternatives throughout the EU. DSM states that the product improves the nutritional profile of plant-based diets and enables the production of fish products based on animals that are similar to present fish products. This omega 3 supplement can be used to boost the nutritious value of foods without harming the marine ecosystem.

Which was the largest region in the omega 3 prescription drugs market?
North America was the largest region in the omega 3 prescription drugs market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omega 3 prescription drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Who are the omega 3 prescription drugs market prominent players?
Major players in the omega 3 prescription drugs market are Abbott Laboratories, Amarin Pharmaceuticals Ireland Ltd., GSK PLC., Natrapharm Inc., Viatris Inc., Grupo Ferrer International SA, Camber Pharmaceuticals Inc., Dr. Reddy’s Laboratories Ltd., Zydus Group, Hikma Pharmaceuticals PLC, KD Pharma Group, and Woodward Pharma Services.

Key omega 3 prescription drugs market segments
The global omega 3 prescription drugs market is segmented –
1) By Drug Type: Vascepa, Lovaza, Other Type
2) By Application Type: Hypertriglyceridemia, Other Application Type
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Request A Sample Of The Global Omega 3 Prescription Drugs Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8091&type=smp

The Omega 3 Prescription Drugs Global Market Report 2023  provides a comprehensive overview on the omega 3 prescription drugs market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Omega-3 Global Market Report 2023
Immune Health Supplements Global Market Report 2023
Bioactive Ingredients Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model